Spain to trial mixing COVID vaccines after restricting AstraZeneca shot

MADRID: Spain will study the effects of mixing different coronavirus vaccines, government researchers said on Monday, responding to shifting guidelines on the safety of the AstraZeneca's shot.

Along with several other European countries, Spain has restricted vaccines produced by the Anglo-Swedish drug maker to people over 60 after regulators linked it to a rare form of brain blood clots, mostly in younger women. "After decisions by various European public health authorities to suspend use of the AstraZeneca vaccine in under 60 year olds, we are setting out to urgently find scientific evidence to support decision making around possible alternatives," Raquel Yotti, director of the Carlos III Health Institute, told a news conference.